Pharmaceutical Industry Blog

Last Updated: July 12, 2026 TL;DR: Thailand — a nation of more than 72 million people with one of Southeast Asia's most developed health systems and universal health coverage delivered through three schemes — depends on a reliable, compliant supply of sterile injectables for its hospitals, its social-insurance programmes and its public procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients.

Last Updated: July 12, 2026 TL;DR: Turkey — a nation of more than 86 million people bridging Europe and Asia, with one of the strongest domestic pharmaceutical industries in the region and an assertive localisation (yerlileştirme) policy — produces most of its medicines locally, yet still imports a significant share of specialised sterile injectables, oncology and biotechnology products and a large proportion of its active pharmaceutical ingredients. Every imported sterile in

Last Updated: July 11, 2026 TL;DR: Iran — a nation of more than 92 million people with one of the most developed domestic pharmaceutical industries in the Middle East — produces most of its medicines locally, yet still relies on imports for a significant share of specialised sterile injectables, oncology and biotech products, and a large proportion of its active pharmaceutical ingredients. Every imported sterile injectable must hold an Iran Registration Code (IRC) issued by t

Last Updated: July 11, 2026 TL;DR: Vietnam — a nation of more than 101 million people and one of the fastest-growing pharmaceutical markets in Southeast Asia — depends on a reliable, compliant supply of sterile injectables for its hospitals, its social-health-insurance programme and its provincial procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients. Every imported sterile injectable must

Last Updated: July 10, 2026 TL;DR: The Democratic Republic of the Congo — the fourth-most-populous country in Africa, home to more than 109 million people — depends almost entirely on imported medicines for its hospitals, its essential-medicines network and its large donor-funded health programmes, because domestic production covers only a small fraction of demand. Every imported sterile injectable must hold a marketing authorisation (Autorisation de Mise sur le Marché, AMM)

Last Updated: July 10, 2026 TL;DR: The Philippines — an archipelago of more than 115 million people and one of the fastest-growing pharmaceutical markets in Southeast Asia — depends on a reliable, compliant supply of sterile injectables for its hospitals, its Universal Health Care programme and its government procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients. Every imported sterile inje